Raymond James & Associates’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$66.1K Buy
2024
Q1
Sell
2023
Q4
$113K Sell
2023
Q3
$82.7K Sell
2023
Q2
$110K Buy
2023
Q1
$113K Buy